Pruritis Clinical Trial
Official title:
A Phase 2 Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy of Dupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic
The goal of this study is to test the efficacy of Dupixent in improving post-burn itching symptoms versus the current standard of care.
Participants will receive six injections of Dupixent or placebo (two 300 mg loading doses and one 300 mg dose every two weeks after that). In addition, they will be asked to complete questionnaires to determine daily itch severity, quality of life, treatment benefit, physical functioning, and pain interference. Individual participants will require 13 weeks to complete all study visits. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04518618 -
Effect of Intrathecal Naloxone in the Incidence of Pruritis After C.S
|
N/A | |
| Completed |
NCT00693654 -
Comparative Study of the Efficacy of SARNA Sensitive Lotion for Treatment of Uremic Itch in Adult Hemodialysis Patients
|
Phase 4 | |
| Completed |
NCT00323154 -
Nalbuphine for the Treatment of Opioid Induced Pruritus in Children
|
Phase 3 | |
| Completed |
NCT03816891 -
Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis
|
Phase 2 | |
| Recruiting |
NCT05936567 -
Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria
|
Phase 2 | |
| Completed |
NCT01114672 -
A Study of Oral Ergocalciferol to Treat Pruritis in Hemodialysis Patients
|
Phase 4 | |
| Withdrawn |
NCT02909569 -
Relieving Chronic Itch: Oral Medication
|
Phase 2 |